Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 17, 2011
View Archived Issues
Analyst: Cash Spent on Stock Is Cash Not Spent on Deals
Read More
Panel: Gene Patents Here to Stay, But Monopolies Aren't
Read More
Money Raised By Biotech in 2011
Read More
Week in Review
Read More
Word on the Street
Read More
Week in Washington
Read More
Top 10 Deals Between Biotech Companies: 2011
Read More
Biotechnology Company Deals With Other Biotechnology Companies: August 1 - October 14, 2011
Read More
Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: August 1 - October 14, 2011
Read More
Biotech-Biotech Collaborations: Modified Agreements: August 1 - October 14, 2011
Read More
Search is on for Incentives To Spark Pediatric Drug R&D
What's it going to take to get biopharma to develop drugs and biologics to treat rare pediatric diseases? That seems to be the million-dollar question as parents, patient advocate groups, doctors and lawmakers search for an answer.
Read More
Money Raised Year to Date
Read More
Stock Gainers and Losers For The Week
Read More
BioWorld Stock Report For Public Biotechnology Companies
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe